Next Article in Journal
Are Vaccines the Solution for Methane Emissions from Ruminants? A Systematic Review
Next Article in Special Issue
Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
Previous Article in Journal
Cell-Based Influenza A/H1N1pdm09 Vaccine Viruses Containing Chimeric Hemagglutinin with Improved Membrane Fusion Ability
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity

1
Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208-3479, USA
2
Immunotherapy, Inflammation and Cancer, Aragon Health Research Institute, Biomedical Research Centre of Aragon, 50009 Zaragoza, Spain
3
The School of Chemistry and Molecular Biosciences, The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane 4072, Australia
*
Author to whom correspondence should be addressed.
Vaccines 2020, 8(3), 459; https://doi.org/10.3390/vaccines8030459
Submission received: 16 July 2020 / Revised: 12 August 2020 / Accepted: 14 August 2020 / Published: 20 August 2020

Abstract

The efficacy of the intranasally (i.n.) delivered live attenuated influenza vaccine (LAIV) is variable and, in some seasons, suboptimal. In this study, we report that LAIV exhibits cross-protective efficacy in mice, potentially associated with cellular immunity as opposed to antigen-specific antibody responses. However, pre-exposure to the intramuscularly (i.m.) delivered inactivated influenza vaccine (IIV) severely impaired LAIV-induced cross-protection against heterologous challenge, potentially by inhibiting replication of LAIV. Our findings suggest that pre-existing immunity afforded by IIV suppresses cross-protective T cell immunogenicity of LAIV.
Keywords: influenza; pre-existing immunity; live attenuated influenza vaccine; inactivated influenza vaccine influenza; pre-existing immunity; live attenuated influenza vaccine; inactivated influenza vaccine

Share and Cite

MDPI and ACS Style

Roy, S.; Williams, C.M.; Pardo, J.; Wijesundara, D.K.; Furuya, Y. Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity. Vaccines 2020, 8, 459. https://doi.org/10.3390/vaccines8030459

AMA Style

Roy S, Williams CM, Pardo J, Wijesundara DK, Furuya Y. Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity. Vaccines. 2020; 8(3):459. https://doi.org/10.3390/vaccines8030459

Chicago/Turabian Style

Roy, Sreeja, Clare M Williams, Julian Pardo, Danushka K Wijesundara, and Yoichi Furuya. 2020. "Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity" Vaccines 8, no. 3: 459. https://doi.org/10.3390/vaccines8030459

APA Style

Roy, S., Williams, C. M., Pardo, J., Wijesundara, D. K., & Furuya, Y. (2020). Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity. Vaccines, 8(3), 459. https://doi.org/10.3390/vaccines8030459

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop